Century Therapeutics (IPSC) Earnings Date & Reports

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IPSC is expected to report earnings to rise 7.09% to -11 cents per share on August 06

Century Therapeutics IPSC Stock Earnings Reports

Q2'26

Est.

$-0.12

Q1'26

Beat

by $0.06

Q4'25

Beat

by $0.05

Q3'25

Missed

by $0.01

Q2'25

Est.

$-0.38

The last earnings report on May 13 showed earnings per share of -10 cents, beating the estimate of -17 cents. With 579.84K shares outstanding, the current market capitalization sits at 413.01M.

View a ticker or compare two or three

Compare

IPSC

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for IPSC